The molecule in a novel eye drop designed by Professor Jonathan Morris at the School of Chemistry has commenced clinical trials

Posted 3 February 2021

Research conducted by UNSW Sydney has paved the way for clinical testing of an eye drop treatment for Diabetic Macular Oedema and wet Age-related Macular Degeneration, the leading causes of blindness in the developed world.

A clinical trial has commenced across Australia for a novel eye drop treatment that could improve the treatment of patients with retinal vascular diseases. Based on initial work carried out at the UNSW School of Chemistry, Professor Jonathan Morris collaborated with Exonate Limited to design the molecule used in the trial.

Please see the UNSW Newsroom item for further information.